TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial. - Xu C; Wang SY; Nie M; Yang KY; Huang XQ; Qu S; Chen H; Shen LF; Huang J; Zhang F; Peng YP; Shi LL; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)